+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels



Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels



Carcinogenesis 17(1): 171-174



Phenobarbital (PB) is a potent tumor promoter in rodent liver. In this study we investigated whether PB selectively promotes a population of initiated cells with reduced levels of transforming growth factor-beta (TGF beta) receptors types I, II and III. Liver tumors were induced in male Fischer F344 rats by diethylnitrosamine (DEN). Following induction the animals were divided into PB-treated (DEN/PB) and untreated groups (DEN). After 3 months of treatment half of the PB-treated rats were removed from PB for the final month (DEN/PB/OFF). At 4 months, the livers from rats in the three treatment groups were removed, tumors excised and frozen with matched surrounding normal liver tissue. The mRNA levels for the TGF beta receptors types I-III were significantly decreased in tumor tissue from DEN/PB rats when compared with surrounding normal liver tissue or tumors from age-matched untreated controls. In tumors from DEN/PB/OFF rats the TGF beta receptor types I-III were also significantly reduced compared with controls and not different to tumors from DEN/PB rats. There was no difference in the mRNA levels for the TGF beta receptors in tumors from rats exposed to DEN alone, when compared with the surrounding normal tissue. These results demonstrate that PB selectively promotes initiated cells with reduced levels of TGF beta types I-III receptors and suggests a mechanistic role for TGF beta in PB-induced liver tumor promotion.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973185

Download citation: RISBibTeXText

PMID: 8565130


Related references

Short Communication: Phenobarbital selectively promotes initiated cells with reduced Tgf receptor levels. Carcinogenesis 17(1): 171-174, 1996

Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-alpha beta cells selectively to the CD8+ cell lineage. Immunology 92(4): 457-464, 1997

Increase in the m6p igf ii receptor and tgf beta 1 levels in hepatocytes exposed to phenobarbital. Proceedings of the American Association for Cancer Research Annual Meeting 32: 158, 1991

Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. Journal of Biological Chemistry 290(24): 14798-14809, 2015

Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. Journal of Immunology 163(7): 4073-4079, 1999

Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferative lesions after short-term exposure in male B6C3F1 mice. Cancer Letters 24(1): 49-55, 1984

Differential regulation of iga production by tgf beta and il 5 tgf beta induces surface iga positive cells bearing il 5 receptor whereas il 5 promotes their survival and maturation into iga secreting cells. Cellular Immunology 140(1): 158-172, 1992

IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells. Journal of Immunology 201(9): 2579-2592, 2018

Beta 2 adrenergic receptor depletion in s49 mouse lymphoma beta p and beta d variant cells is associated with reduced messenger rna and altered glycosylation. FASEB Journal 5(6): A1553, 1991

Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid. Nutrition and Cancer 37(1): 89-98, 2000

Effects of phenobarbital and 5-beta-pregnan-3-alpha-ol-20-one on the GABA-A receptor from CA1 pyramidal cells. Society for Neuroscience Abstracts 19(1-3): 1538, 1993

Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells. Molecular Pharmacology 41(2): 375-381, 1992

Selectively impaired development of intestinal T cell receptor gamma delta+ cells and liver CD4+ NK1+ T cell receptor alpha beta+ cells in T cell factor-1-deficient mice. European Journal of Immunology 26(2): 351-355, 1996

Constitutively active catalytic domain of the insulin receptor promotes phosphorylation and desensitization of the beta-2-adrenergic receptor in Sf9 cells. Society for Neuroscience Abstracts 20(1-2): 18, 1994

Phenobarbital molecularly imprinted polymer selectively binds phenobarbital. Biological and Pharmaceutical Bulletin 20(4): 397-400, 1997